Empirical modeling for glucose control in critical care and diabetes

European Journal of Control

Volumn 11, Issue 6, 2005, Pages 601-616

  Florian, J A ^a   Parker, R S ^a,b  

^a University of Pittsburgh   (United States)

^b 1249 Benedum Hall   (United States)

Author keywords

Critical Care; Diabetes; Identification; Laguerre Basis; Model Predictive Control; Volterra Series

Indexed keywords

ALGORITHMS; CONTROL SYSTEMS; DISEASES; INPUT OUTPUT PROGRAMS; INSULIN; MATHEMATICAL MODELS; PATIENT TREATMENT; PHYSIOLOGICAL MODELS;

CRITICAL CARE; DIABETES; EMPIRICAL VOLTERRA SERIES MODELS; LAGUERRE BASIS; MODEL PREDICTIVE CONTROLS;

GLUCOSE;

EID: 33749651969     PISSN: 09473580     EISSN: None     Source Type: Journal    
DOI: 10.3166/ejc.11.601-618     Document Type: Article

References (65)

1. Bellazzi R, Nucci G, Cobelli C. The subcutaneous route: Closed-loop and partially closed-loop strategies in insulin dependent diabetes mellitus. IEEE Eng Med Biol 2001; 20: 54-64
2. Caduff A, Hirt E, Feldman Y. Ali Z, Heinemann L. First human experiments with a novel non-invasive, non-optical continuous glucose monitoring system. Biosens Bioelectron 2003; 19: 209-217
3. Candas B. Radziuk J. An adaptive plasma glucose controller based on a nonlinear insulin/glucose model. IEEE Trans Biomed Eng 1994; 41: 116-124
4. Cheyne E, Kerr D. Making 'sense' of diabetes: Using a continuous glucose sensor in clinical practice. Diabetes Metab Res Rev 2002; 18(1): S43-S48
5. Cohen A. New disposable electronic micropump for parenteral drug delivery. In: Gurny R, Junginger HE, Peppas NA (eds). Pulsatile drug delivery: current applications and future trends. Wissenschaftliche, Stuttgart, 1993, pp 151-161
6. DCCT - The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986
7. DCCT - The Diabetes Control and Complications Trial Research Group. The absence of a glycemic threshold for the development of long-term complications: The perspective of the diabetes control and complications trial. Diabetes 1996; 45: 1289-1298
8. Demers J, Kane MP, Bakst G, Busch RS, Hamilton RA. Accuracy of home blood glucose monitors using forearm blood samples: Freestyle versus one touch ultra. Am J Health-Syst Pharm 2003; 60: 1130-1135
9. Doyle FJ III, Ogunnaike BA, Pearson RK. Nonlinear model-based control using second-order Volterra models. Automatica 1995; 31: 697-714
10. Dumont GA, Fu Y, and Lu G. Nonlinear adaptive generalized predictive control and applications. In: Clarke D, (ed). Advances in model-based predictive control. Oxford University Press, Oxford, 1994, pp 498-515
11. Finnley SJ, Zekvaeld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003; 290: 2041-2047
12. Fischer U, Schenk W, Salzsieder E, Albrecht G, Abel P, Freyse E-J. Does physiological blood glucose control require an adaptive strategy? IEEE Trans Biomed Eng 1987; 34: 575-582
13. Fisher ME. A semiclosed-loop algorithm for the control of blood glucose levels in diabetics. IEEE Trans Biomed Eng 1991; 38: 57-61
14. Florian JA Jr, and Parker RS. A nonlinear data-driven approach to type I diabetic patient modeling. In: 15th IFAC world congress on automatic control, Barcelona, Spain, 2002 paper #2390
15. Fu Y, and Dumont GA. An optimum time scale for discrete Laguerre network. IEEE Trans Aut Control 1993; 38: 934-938
16. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Flotin HS, Starr A. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003; 125: 1007-1021
17. Garcia CE, Prett DM, Morari M. Model predictive control: Theory and practice - A survey. Automatica 1989; 25(3): 335-348
18. Hernjak N. Doyle FJ III. Glucose control design using nonlinearity assessment techniques. AIChE J 2005; 51: 544-554
19. Hernjak N, Doyle FJ III. Control -relevant nonlinearity analysis of a diabetic patient model. In: AIChE annual meeting, San Francisco, CA, 2003, p 441a
20. Jaremko J, Rorstad O. Advances toward the implantable artificial pancreas for treatment of diabetes. Diabetes Care 1998; 21: 444-450
21. Kerner W. Implantable glucose sensors: Present status and future developments. Exp Clin Endocrinol Diabetes 2001; 109(Suppl. 2): S341-S346
22. Kwok K, Shah SL. Long-range predictive control with a terminal matching condition. Chem Eng Sci 1994; 49: 1287-1300
23. Lehmann ED, Deutsch T. A physiological model of glucose-insulin interaction in type 1 diabetes mellitus. J Biomed Eng 1992; 14: 235-242
24. Linkens DA, Mahfouf M. Generalised predictive control (GPC) in clinical anaesthesia. In: Clarke D, (ed). Advances in model-based predictive control, Oxford University Press, Oxford, 1994, pp 429-445
25. Liu H, Shah S, Jiang W. On-line outlier detection and data cleaning. Comp Chem Eng 2004; 28: 1635-1647
26. Lynch SM, Bequette BW. Model predictive control of blood glucose in type I diabetics using subcutaneous glucose measurements. In: Proceedings of the American Control Conference, vol 5. Anchorage, AK, 2002, pp 4039-4043
27. Malmberg K, Norhammer A, Wedel H, Ryden L. Glycometabolic state at admission: Important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: Long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999; 99: 2626-2632
28. Maran A, Cerpaldi C, Tiengo A, Grassi G, Vitali E, Pagaon G, Bistoni S, Calabrese G, Santeusanio F, Leonetti F, Ribaudo M, DiMario U, Annuzzi G, Genovese S, Riccardi G, Prefiti M, Cucinotta D, Giorgino F, Bellomo A, Biorgino R, Poscia A, Varalli M. Continuous subcutaneous glucose monitoring in diabetic patients: A multicenter analysis. Diabetes Care 2002; 25: 347-352
29. Mayne DQ, Rawlings JB, Rao CV, Scokaert POM. Constrained model predictive control: Stability and optimality. Automatica 2000; 36: 789-814
30. Morari M, Zafiriou E. Robust process control. Prentice-Hall, Englewood Cliffs, NJ, 1989
31. Nowak RD, Van Veen BD. Random and pseudorandom inputs for Volterra filter identification. IEEE Trans Signal Process, 1994; 42(8): 2124-2135
32. Ogunnaike BA. Pearson RK, Samardzija N, Bomberger JD. Low order emprical modeling for nonlinear systems. In: IFAC symposium on advanced control of chemical processes, Kyoto. Japan, 1994, pp 41-46
33. Ollerton RL. Application of optimal control theory to diabetes mellitus. Int J Control 1989; 50: 2503-2522
34. Panjwani P, Sakizlis V, Dua V, Doyle F III. Explicit model based control of blood glucose in type I diabetic patients via parametric programming. In: AIChE Annual Meeting, San Francisco, CA, 2003, p 262e
35. Pannocchia G, Laachi N, Rawlings JB. A fast, easily tuned, SISO, model predictive controller. In: Proceedings of the DYCOPS, Cambridge, MA 2004
36. Parker RS, Doyle FJ III. Control-relevant modeling in drug delivery. Adv. Drug Deliv Rev 2001; 48: 211-228
37. Parker RS, Doyle FJ III. Optimal control of a continuous bioreactor using an empirical non-linear model. Ind Eng Chem Res 2001; 40: 1939-1951
38. Parker RS. Doyle FJ III. Nonlinear model predictive control of a continuous bioreactor at near - optimum conditions. In: Proceedings of the American Control Conference Philadelphia, PA, 1998. New York, NY, pp 2549-2553
39. Parker RS, Doyle FJ III, Peppas N A. The intravenous route to blood glucose control. IEEE Eng Med Biol 2001; 20: 65-73
40. Parker RS, Doyle FJ III, Peppas NA. A model-based algorithm for blood glucose control in type I diabetic patients. IEEE Trans Biomed Eng 1999; 46(2): 148-157
41. Parker RS, Gatzke EP, Doyle FJ III. Advanced model predictive control (MPC) for type I diabetic patient blood glucose control. In: Proceedings of the American Control Conference, vol 5, 2000, pp 3483-3487
42. Parker RS, Harrold JM, Eiseman JL, Zamboni WC, Joseph E, Strychor S, Egorin MJ. Toward model-based chemotherapy treatment design. Dargenio, DZ (ed.) Advanced methods of pharmacokinetic and pharmacodynamic systems analysis, vol III. Kluwer Academic Publishers, Norwell, MA, 2004
43. Parker RS, Heemstra D, Doyle FJ III, Pearson RK, Ogunnaike BA. The identification of nonlinear models for process control using tailored "plant-friendly" input sequences. J Proc Control 2001; 11 (Sp. Issue SI): 237-250
44. Pearson RK, Ogunnaike BA, Doyle FJ III. Identification of structurally constrained second-order Volterra models. IEEE Trans Acoust Speech Sig Proc 1996; 44: 2837-2846
45. ∞ glucose control in diabetes using a physiological model. AIChE J 2000; 46: 2537-2549
46. Potts RO, Tamada JA, Tierney MJ. Glucose monitoring by reverse iontophoresis. Diabetes Metabol Res Rev 2002; 18(Suppl. 1): S49-S53
47. Puckett WR. Dynamic modeling of diabetes mellitus. PhD thesis, Department of Chemical Engineering, University of Wisconsin-Madison, 1992
48. Qin SJ, Badgwell TA. An overview of nonlinear MPC applications. In: Allgöwer F, Zheng A (eds). Nonlinear model predictive control: assessment and future directions. Birkhäuser, Boston, MA, 2000
49. Rao R, Bequette BW, and Roy RJ. Simultaneous regulation of hemodynamic and anesthetic states: A simulation study. Ann Biomed Eng 2000; 28: 71-84
50. Rubb JD, Parker RS. Glucose control in type I diabetic patients: A Volterra model-based approach. In: Proceedings of paper #375 ADCHEM 2003, Hong Kong, PRC 2003
51. Rugh WJ. Nonlinear system theory - The Volterra/ Wiener approach. The Johns Hopkins University Press, Baltimore, MD, 1981
52. Salzsieder E, Albrecht G, Jutzi E, Fischer U. Estimation of individually adapted control parameters for an artificial beta cell. Biomed Biochim Acta 1984; 43: 585-596
53. Schetzen M. The Volterra and Wiener theories of nonlinear systems. John Wiley & Sons, New York, NY, 1980
54. Shangraw RE, Jahoor F, Miyoshi H, Neff WA, Stuart CA, Herndon DN, Wolfe RR. Differentiation between septic and postburn insulin resistance. Metabolism, 1989; 38: 983-989
55. Sorensen JT. A physiologic model of glucose metabolism in man and its use to design and assess improved insulin therapies for diabetes. PhD thesis. Department of Chemical Engineering, MIT, 1985
56. Steil GM, Rebrin K, Janowski R, Darwin C, and Saad MF. Modeling β-cell insulin secretion -Implications for closed-loop glucose homeostasis. Diab Technol Ther 2003; 5: 953-964
57. Steil GM, Rebrin K, Mastrototaro J, Bernaba B, Saad M. Determination of plasma glucose during rapid glucose excursions with a subcutaneous glucose sensor. Diabetes Technol Ther 2003; 5: 27-31
58. Van den Berghe GV, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31(2): 359-66
59. Van den Berghe G, Wouters P, Weekers F. Intensive insulin therapy in critically ill patients. N Engl J Med, 2001; 345: 1359-1367
60. Wada DR and Ward DS. Open loop control of multiple drug effects in anesthesia. IEEE Trans Biomed Eng 1995; 42: 666-677
61. Wolfe RR, Allsop JR, and Burke JF. Glucose metabolism in man: Responses to intravenous glucose infusion. Metabolism 1979; 28: 210-220
62. Wolfe RR, Herndon DN, Jahoor F, Miyoshi H, Wolfe M. Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med 1987; 317:403-408
63. Yu CL, Roy RJ, Kaufman H, Bequette BW. Multiple-model adaptive predictive control of mean arterial blood pressure. IEEE Trans Biomed Eng 1992; 39: 765-778
64. Zafiriou E and Chiou H-W. Output constraint softening for SISO model predictive control. In Proceedings of the American Control Conference, San Francisco, CA, 1993; pp 372-376
65. Zheng Q and Zafiriou E. Nonlinear system identification for control using Volterra-Laguerre expansion. In: Proceedings of the American Control Conference, Seattle, WA, 1995, pp 2195-2199